Left Atrial Appendage Closure Device Market Report 2024, Industry Share and Analysis 2034

 What is the current market size and future outlook for the left atrial appendage closure device market?

The left atrial appendage closure device market size has grown rapidly in recent years. It will grow from $1.67 billion in 2024 to $2 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to prevalence of atrial fibrillation, stroke prevention strategies, clinical evidence and research, minimally invasive alternatives, patient preference for non-pharmacological options, aging population, physician training and expertise.

The left atrial appendage closure device market size is expected to see rapid growth in the next few years. It will grow to $3.74 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to rising global burden of atrial fibrillation, focus on stroke prevention in high-risk patients, expanding patient awareness, integration into standard clinical practice, global efforts in cardiovascular disease management. Major trends in the forecast period include emergence of percutaneous closure techniques, advancements in device designs, increasing use of imaging technologies, focus on minimally invasive approaches, tailored device selection for patient anatomy.



Get Your Free Sample of The Global Left Atrial Appendage Closure Device Market Report:
Left Atrial Appendage Closure Device Market Report 2025, Industry Share and Analysis 2034 Sample

What are the key drivers behind the rapid expansion of the left atrial appendage closure device market?

The rising prevalence of atrial fibrillation is expected to propel the growth of the left atrial appendage (LAA) closure device market going forward. Atrial fibrillation is a medical condition characterized by an irregular and often rapid heartbeat. It occurs when the heart's upper chambers, called the atria, do not beat in a coordinated and rhythmic manner. Left atrial appendage (LAA) closure devices are primarily used in treating atrial fibrillation by reducing the risk of stroke in patients with this cardiac arrhythmia and preventing blood clots from forming or escaping. For instance, in October 2022, according to reports published by the Centers for Disease Control and Prevention, a US-based government agency, atrial fibrillation was the predominant diagnosis in more than 454,000 hospital admissions each year in the US, and it is expected that 12.1 million people in the US will have atrial fibrillation in 2030. Therefore, the rising prevalence of atrial fibrillation is expected to propel the growth of the left atrial appendage (LAA) closure device market.

What is the segmentation for the left atrial appendage closure device market?
The left atrial appendage closure device market covered in this report is segmented –

1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices
2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices

Order your report now for swift delivery
Left Atrial Appendage Closure Device Market Report 2025, Industry Share and Analysis 2034

Who are the most influential companies in the left atrial appendage closure device market?

Major companies operating in the left atrial appendage closure device market report are Johnson And Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Atrium Medical Corporation, Boston Scientific Corporation, Gore Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Dune Medical Devices Ltd., Lifetech Scientific Corporation, Sahajanand Medical Technologies Limited, Occlutech, Cardiva Medical Inc., Sentreheart Inc., Aegis Medical Group, Coherex Medical Inc., EndoStim Inc., Conformal Medical Inc., Cardia Inc., Medical Device Business Service Inc., Protaryx Medical, Append Medical Ltd., Vascular Innovations Co. Ltd., Vivasure Medical Inc., Atritech Inc., CardiaMed AB, Cardialen Inc., Kalila Medical Inc.

What are the most influential trends expected to drive the left atrial appendage closure device market forward?

Major companies operating in the left atrial appendage closure device market are developing innovative products such as Watchman FLX to advance the treatment of non-valvular atrial fibrillation (NVAF) and help patients with an alternative to oral anticoagulation therapy. The Watchman FLX pro device is a self-expandable device implanted in the LAA to block the opening and prevent blood clots from forming. For instance, in September 2022, Boston Scientific Corporation, a US-based manufacturing company, received approval for Watchman FLX from the Food and Drug Administration, a US-based federal agency, to lower the chance of stroke in those with non-valvular atrial fibrillation (NVAF). It is designed to be more flexible and accessible to implant than previous versions of the Watchman device, making it a more viable option for a broader range of patients. Moreover, it is a safe and effective way to reduce the risk of stroke in people with NVAF, and it is a valuable option for patients who are not eligible for oral anticoagulation therapy or who have difficulty managing their oral anticoagulation therapy.

What are the major regional insights for the left atrial appendage closure device market, and which region holds the top position?

North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Left Atrial Appendage Closure Device Market Report 2025 Offer?

The left atrial appendage closure device market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

A left atrial appendage closure device is a medical implant used to treat certain heart conditions, specifically in atrial fibrillation (AF) patients. These devices are implanted in a minimally invasive surgery to lower the risk of stroke in AF patients by sealing off or occluding the left atrial appendage (LAA), preventing blood from entering and clotting.

Purchase the exclusive report now to unlock valuable market insights:
Left Atrial Appendage Closure Device Market Report 2025, Industry Share and Analysis 2034

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Future Outlook of the Electrical And Electronics Ceramics Market: Growth, Trends, and Emerging Opportunities Explored - Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports - By The Business Research Company
Global Market Model: Global Market Intelligence Database